Tech Company Financing Transactions

Constellation Pharmaceuticals Funding Round

Constellation Pharmaceuticals secured a $55 million investment round on 12/10/2015. Investors included Topspin Partners, SR One Capital Management and The Column Group.

Transaction Overview

Company Name
Constellation Pharmaceuticals
Announced On
12/10/2015
Transaction Type
Venture Equity
Amount
$55,000,000
Round
Undisclosed
Investors

Topspin Partners (Lead Investor) (Leo Guthart)

SR One Capital Management (Brian Gallagher)

The Column Group (David Goeddel)

Third Rock Ventures (Mark Levin)

Venrock (Anthony Evnin)

Proceeds Purpose
The Company plans to use the proceeds from the financing to advance its pipeline of direct tumor targeting and immuno-stimulatory epigenetic inhibitors, which includes its two wholly-owned, clinical-stage lead programs: a bromodomain and extra-terminal (BET) inhibitor as well as an EZH2 inhibitor, targeting difficult-to-treat cancers.

Company Information

Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
215 First St. 200
Cambridge, MA 02142
USA
Phone
(617) 714-0555
Website
www.constellationpharma.com
Email Address
[email protected]
Overview
Constellation Pharmaceuticals (Nasdaq: CNST) is the leading biopharmaceutical company dedicated to the development of novel therapeutics in the emerging field of epigenetics.
Profile
Constellation Pharmaceuticals LinkedIn Company Profile
Social Media
Constellation Pharmaceuticals Company Twitter Account
Company News
Constellation Pharmaceuticals News
Facebook
Constellation Pharmaceuticals on Facebook
YouTube
Constellation Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Jigar Raythatha
  Jigar Raythatha LinkedIn Profile  Jigar Raythatha Twitter Account  Jigar Raythatha News  Jigar Raythatha on Facebook
Chief Financial Officer
Emma Reeve
  Emma Reeve LinkedIn Profile  Emma Reeve Twitter Account  Emma Reeve News  Emma Reeve on Facebook
Chief Medical Officer
Adrian Senderowicz
  Adrian Senderowicz LinkedIn Profile  Adrian Senderowicz Twitter Account  Adrian Senderowicz News  Adrian Senderowicz on Facebook
Vice President
Patrick Trojer
  Patrick Trojer LinkedIn Profile  Patrick Trojer Twitter Account  Patrick Trojer News  Patrick Trojer on Facebook
VP - Bus. Development
Brad Prosek
  Brad Prosek LinkedIn Profile  Brad Prosek Twitter Account  Brad Prosek News  Brad Prosek on Facebook
VP - Human Resources
Brenda Sousa
  Brenda Sousa LinkedIn Profile  Brenda Sousa Twitter Account  Brenda Sousa News  Brenda Sousa on Facebook

 

 

Browse more venture capital transactions:

Prev: 12/10/2015: DataScience venture capital transaction
Next: 12/10/2015: Pirch venture capital transaction

 

Share this article

 

About Our Venture Capital Transactions Database

We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.